The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Increased Microglial Exosomal miR-124-3p Alleviates Neurodegeneration and Improves Cognitive Outcome after rmTBI
Open accessAbstract
Repetitive mild traumatic brain injury (rmTBI) is considered to be an important risk factor for long-term neurodegenerative disorders such as Alzheimer's disease, which is characterized by β-amyloid abnormalities and impaired cognitive function. Microglial exosomes have been reported to be involved in the transportation, distribution, and clearance of β-amyloid in Alzheimer's disease. However, their impacts on the development of neurodegeneration after rmTBI are not yet known. The role of miRNAs in microglial exosomes on regulating post-traumatic neurodegeneration was investigated in the present study. We demonstrated that miR-124-3p level in microglial exosomes from injured brain was significantly altered in the acute, sub-acute, and chronic phases after rmTBI. In in vitro experiments, microglial exosomes with upregulated miR-124-3p (EXO-124) alleviated neurodegeneration in repetitive scratch-injured neurons. The effects were exerted by miR-124-3p targeting Rela, an inhibitory transcription factor of ApoE that promotes the β-amyloid proteolytic breakdown, thereby inhibiting β-amyloid abnormalities. In mice with rmTBI, the intravenously injected microglial exosomes were taken up by neurons in injured brain. Besides, miR-124-3p in the exosomes was transferred into hippocampal neurons and alleviated neurodegeneration by targeting the Rela/ApoE signaling pathway. Consequently, EXO-124 treatments improved the cognitive outcome after rmTBI, suggesting a promising therapeutic strategy for future clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When administered intravenously, these exosomes were found to inhibit neuronal inflammation and autophagy, enhance neurogenesis, and consequently improve neurological outcomes in mice [169].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ge et al. discovered that miR-124 is abundantly present in sEVs derived from M2-microglia.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Notably, miR-124-3p within these exosomes was transferred to hippocampal neurons, where it mitigated neurodegeneration by targeting the Rela/ApoE signaling pathway.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [169]
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, in mice models of repetitive mild TBI, these microglial exosomes were observed to be internalized by neurons in the injured brain.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Object recognition test in mice
Leger, M., Quiedeville, A., Bouet, V., Haelewyn, B., Boulouard, M., Schumann-Bard, P., & Freret, T. (2013) · Nature Protocols · doi:10.1038/nprot.2013.155 · Cited by 1,357
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“In addition, the expression of Ab clearance genes could be downregulated with the progression of AD in response to pro-inflammatory cytokines produced by activated microglia.(20,21) These studies suggest that the beneficial/detrimental effects of microglial exosomes are determined by the progressing stages of AD and a…”
BackgroundApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Ponomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787
Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., & Xiong, Y. (2015) · Journal of neurosurgery · doi:10.3171/2014.11.jns14770 · Cited by 737
Incidence of traumatic brain injury in New Zealand: a population-based study
Feigin, V. L., Theadom, A., Barker-Collo, S., Starkey, N. J., McPherson, K., Kahan, M., Dowell, A., Brown, P., Parag, V., Kydd, R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70262-4 · Cited by 729
Traumatic Brain Injury in Older Adults: Epidemiology, Outcomes, and Future Implications
Thompson, H. J., McCormick, W. C., & Kagan, S. H. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00894.x · Cited by 685
Epidemiology of mild traumatic brain injury and neurodegenerative disease
Gardner, R. C., & Yaffe, K. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.001 · Cited by 673
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
Johnson, V. E., Stewart, W., & Smith, D. H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2808 · Cited by 587
The Neuropathology of Chronic Traumatic Encephalopathy
McKee, A. C., Stein, T. D., Kiernan, P. T., & Alvarez, V. E. (2015) · Brain Pathology · doi:10.1111/bpa.12248 · Cited by 585
Hypothalamic stem cells control ageing speed partly through exosomal miRNAs
Zhang, Y., Kim, M. S., Jia, B., Yan, J., Zuniga-Hertz, J. P., Han, C., & Cai, D. (2017) · Nature · doi:10.1038/nature23282 · Cited by 564
McMahon, P. J., Hricik, A. J., Yue, J. K., Puccio, A. M., Inoue, T., Lingsma, H. F., Beers, S. R., Gordon, W. A., Valadka, A. B., Manley, G. T., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.2984 · Cited by 545
Diagnosis, prognosis, and clinical management of mild traumatic brain injury
Levin, H. S., & Diaz-Arrastia, R. R. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00002-2 · Cited by 535
Song, Y., Li, Z., He, T., Qu, M., Jiang, L., Li, W., Shi, X., Pan, J., Zhang, L., Wang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30879 · Cited by 487
Self-citationGlobal neurotrauma research challenges and opportunities
Rubiano, A., Carney, N., Chesnut, R., & Puyana, J. (2015) · Nature · doi:10.1038/nature16035 · Cited by 479
Kim, D.-K., Nishida, H., An, S. Y., Shetty, A. K., Bartosh, T. J., & Prockop, D. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522297113 · Cited by 436
Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
Ramos‐Cejudo, J., Wısnıewskı, T., Marmar, C. R., Zetterberg, H., Blennow, K., de Leon, M. J., & Fossati, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.021 · Cited by 406
Zhang, Y., Chopp, M., Zhang, Z. G., Katakowski, M., Xin, H., Qu, C., Ali, M. M., Mahmood, A., & Xiong, Y. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.08.003 · Cited by 398
Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease
Goetzl, E. J., Kapogiannis, D., Schwartz, J. B., Lobach, I. V., Goetzl, L., Abner, E. L., Jicha, G. A., Karydas, A. M., Boxer, A., & Miller, B. L. (2016) · The FASEB Journal · doi:10.1096/fj.201600816r · Cited by 398
Huang, S., Ge, X., Yu, J., Han, Z., Yin, Z., Li, Y., Chen, F., Wang, H., Zhang, J., & Lei, P. (2018) · The FASEB Journal · doi:10.1096/fj.201700673r · Cited by 388
Self-citationCirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., Hayreh, D., D'Angelo, G., Benzinger, T., Yoon, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107411108 · Cited by 377 · cited 5×
“Stimulation of the 5-hydroxytryptamine receptor on microglia could lead to the release of exosomes containing an insulin-degrading enzyme that targets Ab peptide.53 It explains the phenomenon that an increased level of 5-hydroxytryptamine is associated with a decreased level of Ab in brain tissue of AD.54 Therefore, f…”
BackgroundInfluentialHigh complement levels in astrocyte‐derived exosomes of Alzheimer disease
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., & Kapogiannis, D. (2018) · Annals of Neurology · doi:10.1002/ana.25172 · Cited by 373
Kvartsberg, H., Duits, F. H., Ingelsson, M., Andreasen, N., Öhrfelt, A., Andersson, K., Brinkmalm, G., Lannfelt, L., Minthon, L., Hansson, O., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.10.009 · Cited by 349
Exosomes Derived from Mesenchymal Stromal Cells Promote Axonal Growth of Cortical Neurons
Zhang, Y., Chopp, M., Liu, X., Katakowski, M., Wang, X., Tian, X., Wu, D., & Zhang, Z. G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9851-0 · Cited by 308
Dabrowska, S., Andrzejewska, A., Łukomska, B., & Janowski, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1571-8 · Cited by 304
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
Joshi, P., Turola, E., Ruiz, A., Bergami, A., Libera, D. D., Benussi, L., Giussani, P., Magnani, G., Comı, G., Legname, G., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.180 · Cited by 289
Chen, X., Johnson, V. E., Uryu, K., Trojanowski, J. Q., & Smith, D. H. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00176.x · Cited by 267
Faden, A. I., & Loane, D. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0319-5 · Cited by 245
Increased CSF neurogranin concentration is specific to Alzheimer disease
Wellington, H., Paterson, R. W., Portelius, E., Törnqvist, U., Magdalinou, N., Fox, N. C., Blennow, K., Schott, J. M., & Zetterberg, H. (2016) · Neurology · doi:10.1212/wnl.0000000000002423 · Cited by 232
Serotonin stimulates secretion of exosomes from microglia cells
Glebov, K., Löchner, M., Jabs, R., Lau, T., Merkel, O., Schloss, P., Steinhäuser, C., & Walter, J. (2015) · Glia · doi:10.1002/glia.22772 · Cited by 221
Apolipoprotein E suppresses glial cell secretion of TNFα
Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175
Venkat, P., Cui, C., Chopp, M., Zacharek, A., Wang, F., Landschoot-Ward, J., Shen, Y., & Chen, J. (2019) · Stroke · doi:10.1161/strokeaha.119.025371 · Cited by 172
miR-21 improves the neurological outcome after traumatic brain injury in rats
Ge, X.-T., Lei, P., Wang, H.-C., Zhang, A.-L., Han, Z.-L., Chen, X., Li, S.-H., Jiang, R.-C., Kang, C.-S., & Zhang, J.-N. (2014) · Scientific Reports · doi:10.1038/srep06718 · Cited by 167
Self-citationExploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Cunha, C., Gomes, C., Vaz, A. R., & Brites, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6986175 · Cited by 153
Guadagno, J., Swan, P., Shaikh, R., & Cregan, S. P. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.151 · Cited by 152
Chronic neurodegenerative consequences of traumatic brain injury
Chauhan, N. B. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-130354 · Cited by 133
Microglia-derived extracellular vesicles in Alzheimer’s Disease: A double-edged sword
Trotta, T., Antonietta Panaro, M., Cianciulli, A., Mori, G., Di Benedetto, A., & Porro, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.020 · Cited by 126
Exosomes as Carriers of Alzheimer's Amyloid-ß
Yuyama, K., & Igarashi, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00229 · Cited by 119
miRNA-124 in Immune System and Immune Disorders
Qin, Z., Wang, P., Su, D., & Liu, X. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00406 · Cited by 116
Chen, S., Jiang, S., Zheng, W., Tu, B., Liu, S., Ruan, H., & Fan, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.135 · Cited by 115
Agosta, F., Dalla Libera, D., Spinelli, E. G., Finardi, A., Canu, E., Bergami, A., Bocchio Chiavetto, L., Baronio, M., Comi, G., Martino, G., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24235 · Cited by 113
miR-21 alleviates secondary blood–brain barrier damage after traumatic brain injury in rats
Ge, X., Han, Z., Chen, F., Wang, H., Zhang, B., Jiang, R., Lei, P., & Zhang, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.009 · Cited by 110
Self-citationYu, A., Zhang, T., Duan, H., Pan, Y., Zhang, X., Yang, G., Wang, J., Deng, Y., & Yang, Z. (2017) · Immunology Letters · doi:10.1016/j.imlet.2016.12.003 · Cited by 107
Wnt3a induces exosome secretion from primary cultured rat microglia
Hooper, C., Sáinz‐Fuertes, R., Lynham, S., Hye, A., Killick, R., Warley, A., Bolondi, C., Pocock, J. M., & Lovestone, S. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-144 · Cited by 100
Tarawneh, R. M., Head, D. M., Allison, S. L., Buckles, V., Fagan, A. M., Ladenson, J. H., Morris, J. C., & Holtzman, D. M. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0202 · Cited by 99
Amyloid-beta and tau pathology following repetitive mild traumatic brain injury
Edwards, G., Moreno-Gonzalez, I., & Soto, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.123 · Cited by 96
Ge, X., Huang, S., Gao, H., Han, Z., Chen, F., Zhang, S., Wang, Z., Kang, C., Jiang, R., Yue, S., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.015 · Cited by 86
Self-citationGe, X., Li, W., Huang, S., Yin, Z., Yang, M., Han, Z., Han, Z., Chen, F., Wang, H., Lei, P., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5728 · Cited by 77 · cited 1×
“0 (Promega, Madison, WI, USA), as we previously reported.(23,63) Specifically, the Rela 30 UTR fragments were amplified by PCR (primer sequences: forward, 50-TCTAGACGGTCCTTCAGTTTTTGTGC-30; reverse, 30-TCTA GAAACAGCACACTAAACTACCACG-50) and were inserted into the pGL-3.”
MethodSelf-citationMicrovesicles in the brain: Biomarker, messenger or mediator?
Porro, C., Trotta, T., & Panaro, M. A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.09.006 · Cited by 74
Namjoshi, D., Martin, G., Donkin, J. J., Wilkinson, A., Stukas, S. K., Fan, J., Carr, M., Tabarestani, S., Wuerth, K. C., Hancock, R. E. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053529 · Cited by 56
Laskowitz, D. T., Wang, H., Chen, T., Lubkin, D. T., Cantillana, V., Tu, T. M., Kernagis, D., Zhou, G., Macy, G., Kolls, B. J., et al. (2017) · Scientific Reports · doi:10.1038/srep46461 · Cited by 55
Aβ42 Protofibrils Interact with and Are Trafficked through Microglial-Derived Microvesicles
Gouwens, L. K., Ismail, M. S., Rogers, V. A., Zeller, N. T., Garrad, E. C., Amtashar, F. S., Makoni, N. J., Osborn, D. C., & Nichols, M. R. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00029 · Cited by 48
Peacock, W. F., Meter, T. E. V., Mirshahi, N., Ferber, K., Gerwien, R. W., Rao, V., Sair, H. I., Diaz-Arrastia, R. R., & Korley, F. K. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00641 · Cited by 47
Ge, X., Yu, J., HUANG, S. H., Yin, Z., Han, Z., Chen, F., Wang, Z., Zhang, J., & Lei, P. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.07.021 · Cited by 37
Self-citationHan, Z., Ge, X., Tan, J., Chen, F., Gao, H., Lei, P., & Zhang, J. (2015) · DNA and Cell Biology · doi:10.1089/dna.2015.2800 · Cited by 32
Self-citationStejskal, D., Sporova, L., Švesták, M., & Karpíšek, M. (2011) · Biomedical Papers · doi:10.5507/bp.2011.049 · Cited by 32
The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia
Li, L., Li, Y., Ji, X., Zhang, B., Wei, H. J., & Luo, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.037 · Cited by 28
Self-citationBradley‐Whitman, M. A., Roberts, K. N., Abner, E. L., Scheff, S. W., Lynn, B. C., & Lovell, M. A. (2017) · Brain Injury · doi:10.1080/02699052.2017.1418907 · Cited by 11
Jamal, M., Ito, A., Tanaka, N., Miki, T., Takakura, A., Suzuki, S., Ameno, K., & Kinoshita, H. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1074-6 · Cited by 9
Flagged first, then by citations
Cited by
Sorted by citations
Current Strategies for Exosome Cargo Loading and Targeting Delivery
Zeng, H., Guo, S., Ren, X., Wu, Z., Liu, S., & Yao, X. (2023) · Cells · doi:10.3390/cells12101416 · Cited by 464
Exosomal miRNAs in tumor microenvironment
Tan, S., Xia, L., Yi, P., Han, Y., Tang, L., Pan, Q., Tian, Y., Rao, S., Oyang, L., Liang, J., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01570-6 · Cited by 217
Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
Guo, M., Yin, Z., Chen, F., & Lei, P. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00670-x · Cited by 205
Self-citationNeuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 139
Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
Liao, J., Fan, L., Li, Y., Xu, Q.-Q., Xiong, L., Zhang, S., Liu, J.-H., Xiao, Z.-C., Zhang, C., Yang, J., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.009 · Cited by 119
Self-citation
Metadata
- Authors
- Ge, X., Guo, M., Hu, T., Li, W., Huang, S., Yin, Z., Li, Y., Chen, F., Zhu, L., Kang, C., Jiang, R., Lei, P., & Zhang, J.
- Affiliations
- Tianjin Medical University General Hospital (CN)
- Corresponding author
- Jiang, Rongcai
- Lei, Ping
- Zhang, Jianning
- ORCID
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 28
- Issue
- 2
- Pages
- 503-522
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC7001001
- OpenAlex
- W2990551073
- Cited by
- 242
- References
- 67
- Citations by year
- 2026: 26 · 2025: 50 · 2024: 40 · 2023: 42 · 2022: 37 · 2021: 34 · 2020: 13
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81501055, 81772060, 81720108015, 81671221)
- Tianjin Municipal Science and Technology Commission Natural Fund Project (18JCQNJC81100)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- repetitive mild traumatic brain injury, miR-124-3p, neurodegeneration, cognitive impairment, amyloid-beta, Alzheimer's disease, exosome therapy, hippocampal neurons, microglia
- MeSH terms
- Animals, Apolipoproteins E, Brain Concussion, Cognition, Disease Models, Animal, Male, Models, Biological, Neurons, Severity of Illness Index, Signal Transduction, Microglia, Computational Biology, Neurodegenerative Diseases, Gene Expression Profiling, RNA Interference, MicroRNAs, Mice, Transcription Factor RelA, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
